HSV-1 Infection Among COVID-19 Cases with Ocular and Neurological Manifestations
Open Access
- 30 April 2023
- journal article
- research article
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (1)
Abstract
Introduction: SARS-CoV-2 progression depends on multiple factors, including the compromised immune system and underlying diseases. HSV-1 reactivation in SARS-CoV-2 infection, more likely in patients with pneumonia and immunodeficiency, may be potentially life-threatening and implicate the prognosis. Case Presentation: We report two COVID-19 cases presenting ocular and neurological manifestations suspicious for HSV-1 encephalitis. Conclusions: Our study showed HSV-1 ocular manifestation among two COVID-19 cases. So, the recurrence of HSV-1 infection probably is related to immune responses during COVID-19 pathophysiology.Keywords
This publication has 14 references indexed in Scilit:
- Setting the criteria for SARS-CoV-2 reinfection – six possible casesJournal of Infection, 2021
- Co‐reactivation of the human herpesvirus alpha subfamily (herpes simplex virus‐1 and varicella zoster virus) in a critically ill patient with COVID‐19British Journal of Dermatology, 2020
- Big data and cutaneous manifestations of COVID-19Journal of the American Academy of Dermatology, 2020
- A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 PatientsJournal of Pharmaceutical Research International, 2020
- Diagnosing herpes simplex-1 encephalitis at the time of COVID-19 pandemicNeurological Sciences, 2020
- SARS-CoV-2 and viral sepsis: observations and hypothesesThe Lancet, 2020
- Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?The Lancet, 2020
- Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, ChinaJournal of Medical Virology, 2020
- Influenza Infections and Emergent Viral Infections in Intensive Care UnitSeminars in Respiratory and Critical Care Medicine, 2019
- Risk of Infectious Complications in Patients Taking GlucocorticosteroidsClinical Infectious Diseases, 1989